Potential clinical implications and challenges with the new obesity pharmacotherapies A new era in obesity management Tirzepatide has received FDA and EMA approval for chronic weight management and results in 20% mean WL in people without T2D
Despite inconclusive evidence on the link between IGF-1 and pediatric obesity, some studies have shown that increased circulating IGF-1 in pre-pubertal children with obesity may be associated with increased nutritional status or dysregulation of other hormones [70,71,72,73] Elevated IGF-1, along with hyperinsulinemia, increased leptin, thyroid hormones, and sex steroids, may contribute to accelerated skeletal maturation in children with obesity [74]
Brown MA, Stevenson EJ, Howatson G
S2CID 19814205
Aging results in reduced expression of activating receptors like NKp30 and NKp46, while the expression of inhibitory receptors like KLRG1 and killer cell immunoglobulin-like receptors (KIRs) increases [198, 201, 203]
This expert oversight ensures you get high-quality, effective treatment while minimizing any potential risks
